rs80277041

Variant summary

Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PP4_StrongPM3PM4PP3PP1PM2_Supporting

This summary comes from the ClinGen Evidence Repository: The c.1878G>C; p.Gln626His splicing variant has been reported in at least 5 GT probands (PMIDs: 20020534, 22513797, 25728920, 21113249, 29474205) and co-segregated in one additional affected family member (PMID:22513797). It is absent from ExAC and gnomAD. Flow cytometric studies of the mutant protein expressed in COS-7 cells showed that the mutation did not prevent expression of the GPIIb/IIIa complex on the cell surface (PMID:20020534). However, the mutation was found to result in a splice site error, skipping of exon 18, which could explain the absence of mRNA in the patients (PMID:20020534). Splicing predictors, HSF and MaxEntScan, agree that there is alteration to the WT donor site, most likely affecting splicing. In summary, this variant meets criteria to be classified as pathogenic for GT. GT-specific criteria applied: PM2_Supporting, PM3, PM4, PP3, PP4_Strong, and PP1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA115852/MONDO:0010119/011

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

ITGA2B
NM_000419.5 missense, splice_region

Scores

1
12
6
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic reviewed by expert panel P:2

Conservation

PhyloP100: 2.06
Variant links:
Genes affected
ITGA2B (HGNC:6138): (integrin subunit alpha 2b) This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 11 ACMG points.

PM2
PM3
PM4
PP1
PP3
PP4

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ITGA2BNM_000419.5 linkuse as main transcriptc.1878G>C p.Gln626His missense_variant, splice_region_variant 18/30 ENST00000262407.6
ITGA2BXM_011524749.2 linkuse as main transcriptc.2031G>C p.Gln677His missense_variant, splice_region_variant 18/29
ITGA2BXM_011524750.2 linkuse as main transcriptc.2031G>C p.Gln677His missense_variant, splice_region_variant 18/29

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ITGA2BENST00000262407.6 linkuse as main transcriptc.1878G>C p.Gln626His missense_variant, splice_region_variant 18/301 NM_000419.5 P1P08514-1
ITGA2BENST00000648408.1 linkuse as main transcriptc.1311G>C p.Gln437His missense_variant, splice_region_variant 14/25
ITGA2BENST00000592462.5 linkuse as main transcriptn.673G>C splice_region_variant, non_coding_transcript_exon_variant 7/155

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461638
Hom.:
0
Cov.:
33
AF XY:
0.00000138
AC XY:
1
AN XY:
727120
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Glanzmann thrombasthenia Pathogenic:1
Pathogenic, reviewed by expert panelcurationClinGen Platelet Disorders Variant Curation Expert Panel, ClinGenSep 04, 2020The c.1878G>C; p.Gln626His splicing variant has been reported in at least 5 GT probands (PMIDs: 20020534, 22513797, 25728920, 21113249, 29474205) and co-segregated in one additional affected family member (PMID: 22513797). It is absent from ExAC and gnomAD. Flow cytometric studies of the mutant protein expressed in COS-7 cells showed that the mutation did not prevent expression of the GPIIb/IIIa complex on the cell surface (PMID: 20020534). However, the mutation was found to result in a splice site error, skipping of exon 18, which could explain the absence of mRNA in the patients (PMID: 20020534). Splicing predictors, HSF and MaxEntScan, agree that there is alteration to the WT donor site, most likely affecting splicing. In summary, this variant meets criteria to be classified as pathogenic for GT. GT-specific criteria applied: PM2_Supporting, PM3, PM4, PP3, PP4_Strong, and PP1. -
Glanzmann thrombasthenia 1 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMMar 01, 2010- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Benign
-0.064
T
BayesDel_noAF
Benign
-0.33
CADD
Pathogenic
33
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T
Eigen
Uncertain
0.67
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.77
T
M_CAP
Benign
0.065
D
MetaRNN
Pathogenic
0.84
D
MetaSVM
Uncertain
-0.22
T
MutationAssessor
Uncertain
2.8
M
MutationTaster
Benign
1.0
A;A
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-3.5
D
REVEL
Uncertain
0.40
Sift
Uncertain
0.022
D
Sift4G
Uncertain
0.0030
D
Polyphen
1.0
D
Vest4
0.65
MutPred
0.78
Loss of sheet (P = 0.1398);
MVP
0.84
MPC
0.96
ClinPred
1.0
D
GERP RS
4.5
Varity_R
0.84
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
1.0
SpliceAI score (max)
0.95
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.95
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs80277041; hg19: chr17-42457057; API